Alpha Brain
Alpha Brain Technologies is a neurotechnology company based in the Netherlands focused on developing AI-driven brain monitoring solutions for neurological disorders, primarily epilepsy. Their core product, NEVOA-AI, is an embedded artificial intelligence system designed for real-time brain monitoring using ultra-low-power processors to predict and potentially prevent brain-related catastrophes such as seizures. The company’s first commercial device, NEVOA-E, is a non-invasive, easy-to-wear medical patch that continuously monitors brain activity and alerts patients and caregivers before seizures occur, enabling preventive measures. Alpha Brain collaborates with leading scientific and clinical partners across Europe through projects like RELIEVE and VIEWS, supported by grants from European innovation agencies. Their technology integrates with various brain sensing devices, including wearable EEGs and implantable electrodes, and aims to expand beyond epilepsy to other neurological and neuropsychiatric disorders. The company emphasizes patient-centered design and community engagement, leveraging behavioral science and AI to improve treatment personalization and healthcare outcomes. Alpha Brain operates on a model combining product development and collaborative research, supported by public and innovation funding, positioning itself as a pioneer in AI-enabled continuous brain health monitoring.
Alpha Brain
Alpha Brain Technologies is a neurotechnology company based in the Netherlands focused on developing AI-driven brain monitoring solutions for neurological disorders, primarily epilepsy. Their core product, NEVOA-AI, is an embedded artificial intelligence system designed for real-time brain monitoring using ultra-low-power processors to predict and potentially prevent brain-related catastrophes such as seizures. The company’s first commercial device, NEVOA-E, is a non-invasive, easy-to-wear medical patch that continuously monitors brain activity and alerts patients and caregivers before seizures occur, enabling preventive measures. Alpha Brain collaborates with leading scientific and clinical partners across Europe through projects like RELIEVE and VIEWS, supported by grants from European innovation agencies. Their technology integrates with various brain sensing devices, including wearable EEGs and implantable electrodes, and aims to expand beyond epilepsy to other neurological and neuropsychiatric disorders. The company emphasizes patient-centered design and community engagement, leveraging behavioral science and AI to improve treatment personalization and healthcare outcomes. Alpha Brain operates on a model combining product development and collaborative research, supported by public and innovation funding, positioning itself as a pioneer in AI-enabled continuous brain health monitoring.
TL;DR
What they do: Netherlands-based neurotech building ultra-low-power AI for real-time brain monitoring, initially targeting epilepsy seizure prediction.
Flagship products: NEVOA-AI (embedded AI for implants/wearables) and NEVOA-E (non-invasive wearable seizure-prediction patch).
HQ & founding: Founded in the Netherlands (Maastricht indicated); founded year 2011.
Team size: Approximately 7 employees.
Supported by public/innovation grants and programs and accelerator support (EIC Pathfinder Open, RVO, ZonMw, Health~Holland, EY Startup Academy).